TipRanks
STELLA PHARMA CORPORATION (JP:4888)
:4888
Japanese Market
Want to see JP:4888 full AI Analyst Report?

STELLA PHARMA CORPORATION (4888) Income Statement

0 Followers

STELLA PHARMA CORPORATION Income Statement

Last quarter (Q1 2026), STELLA PHARMA CORPORATION's total revenue was ¥92.40M, a decrease of 0.00% from the same quarter last year. In Q1, STELLA PHARMA CORPORATION's net income was ¥-228.83M. See STELLA PHARMA CORPORATION’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 323.39M¥ 961.06M¥ 269.49M¥ 229.07M¥ 100.10M
Gross Profit
¥ 250.56M¥ 828.72M¥ 203.69M¥ 192.36M¥ 50.73M
Operating Expenses
¥ 999.51M¥ 918.97M¥ 963.99M¥ 999.13M¥ 792.63M
Depreciation and Amortization
¥ 28.60M¥ 34.72M¥ 35.04M¥ 35.05M¥ 34.13M
EBITDA
¥ -742.15M¥ -99.06M¥ -723.85M¥ -738.35M¥ -726.86M
Operating Income
¥ -748.96M¥ -90.25M¥ -760.30M¥ -806.77M¥ -741.90M
Other Income/Expenses
¥ -29.05M¥ -47.62M¥ -676.00K¥ 30.80M¥ -22.18M
Pretax Income
¥ -778.00M¥ -137.87M¥ -760.98M¥ -775.97M¥ -764.09M
Net Income
¥ -780.92M¥ -140.81M¥ -763.75M¥ -778.82M¥ -767.72M
Per Share Metrics
Basic EPS
¥ -22.95¥ -4.22¥ -24.66¥ -26.97¥ -26.77
Diluted EPS
¥ -22.95¥ -4.22¥ -24.66¥ -26.97¥ -26.77
Weighted Average Shares Outstanding
34.02M 33.38M 30.98M 28.88M 28.68M
Weighted Average Shares Outstanding (Diluted)
34.02M 33.38M 30.98M 28.88M 28.68M
Currency in JPY

STELLA PHARMA CORPORATION Earnings and Revenue History